Alcohol Use Disorder, Opioid Agonist Treatment, Opioid Use Disorder
Conditions
Keywords
Research surveys, App based program, Smartphone
Brief summary
This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.
Interventions
BEHAVIORALDigital Contingency Management Intervention Arm
Participants will use a version of the app for 6-months. Participants in this group may earn rewards for completing recovery-related activities and for abstinence from drugs and alcohol. During the 6 months this will include: random saliva drug tests, breathalyzer tests, and video selfies, completing surveys and questionnaires through the app, and receiving rewards on a debit card for abstinent tests, surveys, and activities. Additionally, participants will complete follow-up at approximately 9 months after randomization.
BEHAVIORALDigital Wellness Arm
Participants will use a version of the app for 6-months focussed on wellness. During the 6 months this will include: random requests to do saliva drug tests, breathalyzer tests, and video selfies, complete surveys and questionnaires through the app, and receive rewards on a debit card for completing tests, surveys, and activities. Participants in this group may also earn rewards for completing study activities like tests and surveys. Additionally, participants will complete follow-up at approximately 9 months after randomization.
Sponsors
University of Michigan
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
DynamiCare Health
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
19 Years to 63 Years
Healthy volunteers
No
Inclusion criteria
* Participants must be enrolled in the Michigan Medicaid program * Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone * Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening * Participants must have regular access to a working smartphone and internet connection. * Participants must have a reliable mailing address to receive study supplies (e.g., salivary drug tests).
Exclusion criteria
* Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid claims data for this group * Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency * Individuals with substantial cognitive impairment that would interfere with study participation * Individuals unable to read or understand English * Individuals experiencing active suicidality or psychosis. * Individuals with a planned admission to residential treatment or incarceration during the study period.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility based on recruitment | Recruitment period 12 months | Recruitment: ≥60% of participants enrolled |
| Feasibility based on adherence | 6 months (during the Dynamicare program) | Adherence: ≥50% of app-based, biochemically-verified tests completed in the digital CM condition. |
| Feasibility based on Retention | 6 months | Retention: ≥70% of participants retained at 6 months |
| Acceptability of the intervention | 3-month after starting program | Defined as \>70% of participants rating the intervention experience ≥ 4/5 on the Acceptability of Intervention Measure |
Countries
United States
Contacts
CONTACTHaley Stevens
PRINCIPAL_INVESTIGATORLara Coughlin, PhD
University of Michigan
PRINCIPAL_INVESTIGATORAnne C Fernandez, PhD
Rutgers University
Outcome results
None listed